{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:33:56Z","timestamp":1791606836389,"version":"4.3.4"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["No 721746"],"award-info":[{"award-number":["No 721746"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["MA-COE128-002"],"award-info":[{"award-number":["MA-COE128-002"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","award":["MR\/Y015479\/1"],"award-info":[{"award-number":["MR\/Y015479\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006219","name":"Kurt Weill Foundation for Music","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00513"],"award-info":[{"award-number":["PI23\/00513"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["24YOUN08"],"award-info":[{"award-number":["24YOUN08"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MCI23025"],"award-info":[{"award-number":["MCI23025"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016015","name":"Universit\u00e4tsspital Basel","doi-asserted-by":"publisher","award":["PMC Platform"],"award-info":[{"award-number":["PMC Platform"]}],"id":[{"id":"10.13039\/100016015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022217","name":"Flinders Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017453","name":"Institute for Prostate Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023479","name":"CRIS Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016930"],"award-info":[{"award-number":["2016930"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2037416"],"award-info":[{"award-number":["2037416"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1196225"],"award-info":[{"award-number":["1196225"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2011033"],"award-info":[{"award-number":["2011033"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Dutch Cancer Society","doi-asserted-by":"publisher","award":["EMCR 2015-8037"],"award-info":[{"award-number":["EMCR 2015-8037"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","award":["Global Action Plan 1"],"award-info":[{"award-number":["Global Action Plan 1"]}],"id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["2022-CP-IDMH-019"],"award-info":[{"award-number":["2022-CP-IDMH-019"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["C -PJ-126-Exper-2019"],"award-info":[{"award-number":["C -PJ-126-Exper-2019"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006548","name":"KWF","doi-asserted-by":"publisher","award":["Young investigator grant 14806"],"award-info":[{"award-number":["Young investigator grant 14806"]}],"id":[{"id":"10.13039\/501100006548","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP230100609"],"award-info":[{"award-number":["DP230100609"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Kommission zur F\u00f6rderung der wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023856","name":"EJ Whitten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Swiss Cancer League","doi-asserted-by":"publisher","award":["KLS -5654-08-2022"],"award-info":[{"award-number":["KLS -5654-08-2022"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["No 860303"],"award-info":[{"award-number":["No 860303"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101168661"],"award-info":[{"award-number":["101168661"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["APP1187030"],"award-info":[{"award-number":["APP1187030"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["2023 _PCRS_0269"],"award-info":[{"award-number":["2023 _PCRS_0269"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U 01 CA224044"],"award-info":[{"award-number":["U 01 CA224044"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council New South Wales","doi-asserted-by":"publisher","award":["RG23-04"],"award-info":[{"award-number":["RG23-04"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council New South Wales","doi-asserted-by":"publisher","award":["RG25-13"],"award-info":[{"award-number":["RG25-13"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008914","name":"Advance Queensland","doi-asserted-by":"publisher","award":["AQIRF066-2019RD2"],"award-info":[{"award-number":["AQIRF066-2019RD2"]}],"id":[{"id":"10.13039\/501100008914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C1994\/A28701"],"award-info":[{"award-number":["C1994\/A28701"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5759\/A27412"],"award-info":[{"award-number":["C5759\/A27412"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII 5 _202297"],"award-info":[{"award-number":["CRSII 5 _202297"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030 _215517"],"award-info":[{"award-number":["310030 _215517"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030 _205086"],"award-info":[{"award-number":["320030 _205086"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_189149"],"award-info":[{"award-number":["310030_189149"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS4960-02-2020"],"award-info":[{"award-number":["KFS4960-02-2020"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5552-02-2022"],"award-info":[{"award-number":["KFS-5552-02-2022"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-4983-02-2020"],"award-info":[{"award-number":["KFS-4983-02-2020"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","award":["MCRF18017"],"award-info":[{"award-number":["MCRF18017"]}],"id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","award":["MCRF15023"],"award-info":[{"award-number":["MCRF15023"]}],"id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017342","name":"Cancer Center, Medical College of Wisconsin","doi-asserted-by":"publisher","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}],"id":[{"id":"10.13039\/100017342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021954","name":"Tour de Cure Limited","doi-asserted-by":"publisher","award":["RSP-665-FY2023"],"award-info":[{"award-number":["RSP-665-FY2023"]}],"id":[{"id":"10.13039\/501100021954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA255259"],"award-info":[{"award-number":["R01 CA255259"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30ES027792"],"award-info":[{"award-number":["P30ES027792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1CA163227"],"award-info":[{"award-number":["PO1CA163227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA279993"],"award-info":[{"award-number":["R01CA279993"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R50CA274336"],"award-info":[{"award-number":["R50CA274336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000927","name":"Prostate Cancer Foundation of Australia","doi-asserted-by":"publisher","award":["Priority Impact Research Award \\u2013 Future Leader PIRA FLECR-0523"],"award-info":[{"award-number":["Priority Impact Research Award \\u2013 Future Leader PIRA FLECR-0523"]}],"id":[{"id":"10.13039\/501100000927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006069","name":"Cancer League of Basel","doi-asserted-by":"publisher","award":["KLbB-5329-03-2021"],"award-info":[{"award-number":["KLbB-5329-03-2021"]}],"id":[{"id":"10.13039\/501100006069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218791","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:22:17Z","timestamp":1787152937000},"page":"218791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis"],"prefix":"10.1016","volume":"659","author":[{"given":"Cl\u00e9mentine","family":"Le Magnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Nathaniel","family":"Brennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Aytes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Wai","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee K.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilsa M.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Dinevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Doultsinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Edge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Labanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Luna-Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Karthaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Kruithof-de Julio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Philp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail S.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weranja","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Selth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Taubenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renea A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Timpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske M.","family":"van Weerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail P.","family":"Risbridger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-3000","authenticated-orcid":false,"given":"Mitchell G.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218791_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.canlet.2026.218791_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41585-022-00706-x","article-title":"The future of patient-derived xenografts in prostate cancer research","volume":"20","author":"Lawrence","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/pros.23701","article-title":"Movember GAP1 PDX project: an international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models","volume":"78","author":"Navone","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030528","article-title":"Genetically engineered mouse models of prostate cancer in the postgenomic era","volume":"9","author":"Arriaga","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pros.24682","article-title":"Defining the challenges and opportunities for using patient-derived models in prostate cancer research","volume":"84","author":"Brennen","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2026.03.007","article-title":"Unveiling the clinical potential of prostate cancer three-dimensional models: a systematic review","author":"Peyrottes","year":"2026","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.canlet.2026.218791_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169616","article-title":"Prostate organoids: emerging experimental tools for translational research","volume":"133","author":"Beshiri","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218791_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/cancers17040682","article-title":"Ancestry-specific DNA damage repair gene mutations and prostate cancer","volume":"17","author":"Borbiev","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218791_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218791_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/ijms24010674","article-title":"How the analysis of the pathogenetic variants of DDR genes will change the management of prostate cancer patients","volume":"24","author":"Sciarra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218791_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1231536","article-title":"Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer","volume":"14","author":"Bugoye","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2026.218791_bib12","article-title":"UK-based clinical testing programme for somatic and germline BRCA1\/2, ATM and CDK12 mutations in prostate cancer: first results","volume":"4","author":"Evans","year":"2025","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.canlet.2026.218791_bib13","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1172\/JCI132031","article-title":"Genomics of lethal prostate cancer at diagnosis and castration resistance","volume":"130","author":"Mateo","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218791_bib14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/pros.24918","article-title":"Germline testing for prostate cancer patients: evidence-based evaluation of genes recommended by NCCN guidelines","volume":"85","author":"Xu","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41598-020-79663-7","article-title":"Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PPO.0000000000000738","article-title":"Immunoprevention strategies for colorectal cancer in Lynch syndrome carriers","volume":"30","author":"Bowen","year":"2024","journal-title":"Cancer J."},{"key":"10.1016\/j.canlet.2026.218791_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-069X-10-9","article-title":"Knowns and unknowns on burden of disease due to chemicals: a systematic review","volume":"10","author":"Pr\u00fcss-Ust\u00fcn","year":"2011","journal-title":"Environ. Health"},{"key":"10.1016\/j.canlet.2026.218791_bib18","series-title":"Nutr. Oncol. Nutr. Cancer Prev. Treat. Surviv.","article-title":"Environmental factors in cancer risk","author":"Xie","year":"2021"},{"key":"10.1016\/j.canlet.2026.218791_bib19","series-title":"Issues Toxicol","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1039\/9781849734660-00331","article-title":"CHAPTER 12. Environmental chemicals and prostate cancer risk","author":"Joneja","year":"2012"},{"key":"10.1016\/j.canlet.2026.218791_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12940-020-00583-0","article-title":"Pesticide exposure and risk of aggressive prostate cancer among private pesticide applicators","volume":"19","author":"Pardo","year":"2020","journal-title":"Environ. Health"},{"key":"10.1016\/j.canlet.2026.218791_bib21","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/er.2015-1010","article-title":"EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.canlet.2026.218791_bib22","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.3390\/nu13113902","article-title":"Per- and polyfluoroalkyl substance exposure combined with high-fat diet supports prostate cancer progression","volume":"13","author":"Imir","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.canlet.2026.218791_bib23","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.3390\/cancers14122919","article-title":"Toward a mechanistic understanding of Poly- and perfluoroalkylated substances and cancer","volume":"14","author":"Boyd","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218791_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115718","article-title":"A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk","volume":"228","author":"Rhee","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.canlet.2026.218791_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.envint.2013.10.005","article-title":"Case\u2013control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer","volume":"63","author":"Hardell","year":"2014","journal-title":"Environ. Int."},{"key":"10.1016\/j.canlet.2026.218791_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ajim.23454","article-title":"Occupational exposure and serum levels of per\u2010 and polyfluoroalkyl substances (PFAS): a review","volume":"66","author":"Lucas","year":"2023","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1289\/ehp.10423","article-title":"Inorganic arsenic and human prostate cancer","volume":"116","author":"Benbrahim-Tallaa","year":"2008","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.canlet.2026.218791_bib28","doi-asserted-by":"crossref","DOI":"10.1289\/EHP6471","article-title":"Effects of inorganic arsenic on human prostate stem-progenitor cell transformation, autophagic flux blockade, and NRF2 pathway activation","volume":"128","author":"Xie","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.canlet.2026.218791_bib29","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijerph21111532","article-title":"The association between cadmium exposure and prostate cancer: an updated systematic review and meta-analysis","volume":"21","author":"Firmani","year":"2024","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.canlet.2026.218791_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110680","article-title":"Mechanisms of action of agrochemicals acting as endocrine disrupting chemicals","volume":"502","author":"Warner","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2026.218791_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1210\/endo.143.1.8581","article-title":"Role of cadmium in the regulation of AR gene expression and activity","volume":"143","author":"Martin","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2026.218791_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12940-025-01188-1","article-title":"Per- and polyfluoroalkyl substances (PFAS), thyroid hormones, sexual hormones and pubertal development in adolescents residing in the neighborhood of a 3M factory","volume":"24","author":"Van Larebeke","year":"2025","journal-title":"Environ. Health"},{"key":"10.1016\/j.canlet.2026.218791_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114902","article-title":"Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells","volume":"197","author":"Hu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218791_bib34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/pros.20959","article-title":"High\u2010resolution array CGH identifies novel regions of genomic alteration in intermediate\u2010risk prostate cancer","volume":"69","author":"Ishkanian","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/0008-5472.CAN-22-1065","article-title":"Establishment of the LNCaP cell line \u2013 the dawn of an era for prostate cancer research","volume":"82","author":"Abate-Shen","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H","article-title":"Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines","volume":"28","author":"Rauh-Adelmann","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2026.218791_bib37","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3390\/ijms25116111","article-title":"Genomic characterization of preclinical prostate cancer cell line models","volume":"25","author":"Beatson","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218791_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000995","article-title":"Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis","volume":"6","author":"Francis","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2026.218791_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11626-006-0009-7","article-title":"Molecular analysis and characterization of PrEc, commercially available prostate epithelial cells, vitro cell","volume":"42","author":"Sobel","year":"2006","journal-title":"Dev. Biol. - Anim."},{"key":"10.1016\/j.canlet.2026.218791_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/pros.22828","article-title":"Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR\/\u03b2\u2010catenin\/TCF\u20104 complex inhibition of c\u2010MYC transcription","volume":"74","author":"Antony","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib41","author":"Yang"},{"key":"10.1016\/j.canlet.2026.218791_bib42","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1158\/0008-5472.CAN-04-1601","article-title":"Defective DNA strand break repair after DNA damage in prostate cancer cells","volume":"64","author":"Fan","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/pros.10244","article-title":"Intermediate basal cells of the prostate: in vitro and in vivo characterization","volume":"55","author":"Garraway","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib44","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1158\/0008-5472.CAN-06-1228","article-title":"Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells","volume":"66","author":"Litvinov","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib45","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/pros.22828","article-title":"Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR\/\u03b2-catenin\/TCF-4 complex inhibition of c-MYC transcription","volume":"74","author":"Antony","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71306-5","article-title":"Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT","volume":"14","author":"Wasserman","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib47","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yexcr.2007.08.011","article-title":"Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells","volume":"314","author":"Li","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2026.218791_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nprot.2013.043","article-title":"A preclinical xenograft model of prostate cancer using human tumors","volume":"8","author":"Lawrence","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2026.218791_bib49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41467-023-36211-x","article-title":"DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation","volume":"14","author":"Kwon","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.eururo.2020.10.029","article-title":"Advanced prostate cancer with ATM loss: PARP and ATR inhibitors","volume":"79","author":"Neeb","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib51","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1038\/s41467-025-63168-w","article-title":"A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells","volume":"16","author":"Jones","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib52","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1038\/s41467-020-20055-w","article-title":"Quantifying the influence of mutation detection on tumour subclonal reconstruction","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/pros.23510","article-title":"The what, when, and why of human prostate cancer xenografts","volume":"78","author":"Brennen","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218791_bib55","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ncb3047","article-title":"Single luminal epithelial progenitors can generate prostate organoids in culture","volume":"16","author":"Chua","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218791_bib56","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-13-2921-T","article-title":"High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development","volume":"74","author":"Lin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib57","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3390\/cells11223632","article-title":"Patient-derived xenografts and organoids recapitulate castration-resistant prostate cancer with sustained androgen receptor signaling","volume":"11","author":"Van Hemelryk","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218791_bib58","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1158\/1078-0432.CCR-20-0479","article-title":"The MD anderson prostate cancer patient-derived xenograft series (MDA PCa PDX) captures the molecular landscape of prostate cancer and facilitates marker-driven therapy development","volume":"26","author":"Palanisamy","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib59","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41467-021-25175-5","article-title":"The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology","volume":"12","author":"Risbridger","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146827","article-title":"Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer","volume":"6","author":"Brennen","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2026.218791_bib61","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pros.23313","article-title":"LuCaP prostate cancer patient-derived xenografts reflect the molecular heterogeneity of advanced disease an--d serve as models for evaluating cancer therapeutics","volume":"77","author":"Nguyen","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib62","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1158\/1078-0432.CCR-23-2438","article-title":"Integrative molecular analyses of the MD anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series","volume":"30","author":"Anselmino","year":"2024","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/path.5652","article-title":"Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer","volume":"254","author":"Porter","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218791_bib64","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-18-0409","article-title":"A PDX\/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening","volume":"24","author":"Beshiri","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib65","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186599","article-title":"Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer","volume":"135","author":"Roudier","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218791_bib66","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.euf.2025.03.017","article-title":"Reprogramming of androgen receptor activity in castration-resistant prostate cancer is shaped by truncated variants","volume":"11","author":"Lawrence","year":"2025","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.canlet.2026.218791_bib67","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-13-2876","article-title":"Androgen receptor splice variants determine taxane sensitivity in prostate cancer","volume":"74","author":"Thadani-Mulero","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2021.11.004","article-title":"Patient-derived xenograft models of neuroendocrine prostate cancer","volume":"525","author":"Shi","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218791_bib69","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218791_bib70","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.eururo.2018.06.020","article-title":"Patient-derived models of Abiraterone- and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy","volume":"74","author":"Lawrence","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib71","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eururo.2017.02.038","article-title":"Stromal gene expression is predictive for metastatic primary prostate cancer","volume":"73","author":"Mo","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib72","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eururo.2005.12.035","article-title":"The human PC346 xenograft and cell line panel: a model system for prostate cancer progression","volume":"49","author":"Marques","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib73","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1038\/s41467-021-25177-3","article-title":"Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41588-020-00750-6","article-title":"PDXNET consortium, EurOPDX consortium, conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts","volume":"53","author":"Woo","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218791_bib76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-022-00268-6","article-title":"DNA-Based copy number analysis confirms genomic evolution of PDX models","volume":"6","author":"Hoge","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218791_bib77","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1158\/1541-7786.MCR-21-1037","article-title":"Modeling androgen deprivation therapy\u2013induced prostate cancer dormancy and its clinical implications","volume":"20","author":"Dong","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib78","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1038\/s41388-020-01479-6","article-title":"Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors","volume":"39","author":"Zhu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218791_bib79","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/stem.668","article-title":"Brief report: a bioassay to identify primary human prostate cancer repopulating cells","volume":"29","author":"Toivanen","year":"2011","journal-title":"Stem Cells Dayt. Ohio"},{"key":"10.1016\/j.canlet.2026.218791_bib80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2022.01.028","article-title":"Racial disparities in prostate cancer: a complex interplay between socioeconomic inequities and genomics","volume":"531","author":"Lowder","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218791_bib81","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/s41588-024-01931-3","article-title":"Heterogeneous genetic architectures of prostate cancer susceptibility in Sub-Saharan Africa","volume":"56","author":"Janivara","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218791_bib82","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41588-024-02068-z","article-title":"Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups","volume":"57","author":"Hoffmann","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218791_bib83","first-page":"144","article-title":"Genetics of prostate cancer","volume":"23","author":"Shevach","year":"2025","journal-title":"Clin. Adv. Hematol. Oncol. HO"},{"key":"10.1016\/j.canlet.2026.218791_bib84","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41391-021-00460-y","article-title":"Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry","volume":"25","author":"Patierno","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2026.218791_bib85","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/cas.14935","article-title":"Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13","volume":"112","author":"Okasho","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218791_bib86","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41585-019-0234-y","article-title":"The need for cell lines from diverse ethnic backgrounds for prostate cancer research","volume":"16","author":"Badal","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib87","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1158\/0008-5472.CAN-17-0582","article-title":"PDX-MI: minimal information for patient-derived tumor xenograft models","volume":"77","author":"Meehan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib88","series-title":"FDA Announces Plan to Phase out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs","year":"2025"},{"key":"10.1016\/j.canlet.2026.218791_bib89","unstructured":"Roadmap towards phasing out animal testing, European comission, n.d. https:\/\/single-market-economy.ec.europa.eu\/sectors\/chemicals\/reach\/roadmap-towards-phasing-out-animal-testing_en."},{"key":"10.1016\/j.canlet.2026.218791_bib90","series-title":"NIH Establishes Nation's First Dedicated Organoid Development Center to Reduce Reliance on Animal Modeling","year":"2025"},{"key":"10.1016\/j.canlet.2026.218791_bib91","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","article-title":"Identification of multipotent luminal progenitor cells in human prostate organoid cultures","volume":"159","author":"Karthaus","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218791_bib92","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.aay0267","article-title":"Regenerative potential of prostate luminal cells revealed by single-cell analysis","volume":"368","author":"Karthaus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218791_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102640","article-title":"Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids","volume":"24","author":"McCray","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218791_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218791_bib95","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218791_bib96","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.5698","article-title":"Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens","volume":"254","author":"Servant","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218791_bib98","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.641980","article-title":"Patient-derived cancer organoids as predictors of treatment response","volume":"11","author":"Verduin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218791_bib100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2021.03.023","article-title":"Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells","volume":"150","author":"Mout","year":"2021","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"10.1016\/j.canlet.2026.218791_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2026.104486","article-title":"Protocol for generating and characterizing Matrigel-free prostate cancer patient-derived organoids","volume":"7","author":"Dolgos","year":"2026","journal-title":"STAR Protoc."},{"key":"10.1016\/j.canlet.2026.218791_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116352","article-title":"Single-cell analysis uncovers preserved prostate cancer lineages and universally altered pathways in Matrigel-free patient-derived organoids","volume":"44","author":"Dolgos","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-18-1912","article-title":"A phase II trial of the Aurora kinase A inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: efficacy and biomarkers","volume":"25","author":"Beltran","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib104","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","article-title":"Clinical applications of human organoids","volume":"31","author":"Verstegen","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib105","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/cells12101377","article-title":"Viability analysis and high-content live-cell imaging for drug testing in prostate cancer xenograft-derived organoids","volume":"12","author":"Van Hemelryk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218791_bib106","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.6280","article-title":"Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer","volume":"263","author":"Choo","year":"2024","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218791_bib107","first-page":"1107","article-title":"High-throughput imaging assay for drug screening of 3D prostate cancer organoids","volume":"26","author":"Choo","year":"2021","journal-title":"SLAS Discov. Adv. Life Sci. R D"},{"key":"10.1016\/j.canlet.2026.218791_bib108","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/1535-7163.MCT-20-0932","article-title":"CX-5461 sensitizes DNA damage repair-proficient castrate-resistant prostate cancer to PARP inhibition","volume":"20","author":"Lawrence","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218791_bib109","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41467-021-21300-6","article-title":"Patient-derived xenografts and organoids model therapy response in prostate cancer","volume":"12","author":"Karkampouna","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218791_bib110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2022.09.004","article-title":"B7-H3 as a therapeutic target in advanced prostate cancer","volume":"83","author":"Guo","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2026.218791_bib111","article-title":"Extracellular matrix in synthetic hydrogel-based prostate cancer organoids regulate therapeutic response to EZH2 and DRD2 inhibitors","volume":"34","author":"Mosquera","year":"2022","journal-title":"Adv. Mater. Deerfield Beach Fla"},{"key":"10.1016\/j.canlet.2026.218791_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02874-8","article-title":"A single-chain derivative of an integrin-activating antibody potentiates organoid growth in matrigel and collagen hydrogels","author":"de Lau","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218791_bib113","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.euo.2021.10.001","article-title":"Fibroblast growth factor receptor 1 drives the metastatic progression of prostate cancer","volume":"5","author":"Labanca","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.canlet.2026.218791_bib114","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pros.24297","article-title":"Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling","volume":"82","author":"Moll","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib115","article-title":"ECM-Mimicking hydrogel models of human adipose tissue identify deregulated lipid metabolism in the prostate cancer-adipocyte crosstalk under antiandrogen therapy","volume":"30","author":"Bessot","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.canlet.2026.218791_bib116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1615\/CritRevOncog.2022043441","article-title":"The challenges and emerging opportunities of targeting cytokines and chemokine-driven inflammatory signals in metastatic castrate-resistant prostate cancer","volume":"27","author":"Waugh","year":"2022","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.canlet.2026.218791_bib117","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.3390\/cancers12123786","article-title":"Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals prognostic value of stroma signatures","volume":"12","author":"Karkampouna","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218791_bib118","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/1541-7786.MCR-18-0500","article-title":"Interactions with muscle cells boost fusion, stemness, and drug resistance of prostate cancer cells","volume":"17","author":"Uygur","year":"2019","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.canlet.2026.218791_bib119","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s12013-024-01569-2","article-title":"Immune effect of Co-Culture of dendritic cells and cytokine-induced killer cells on prostate cancer cells","volume":"83","author":"Li","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.canlet.2026.218791_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg2564","article-title":"In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer","volume":"7","author":"Bock","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218791_bib121","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.actbio.2024.02.025","article-title":"Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo","volume":"178","author":"Paindelli","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.canlet.2026.218791_bib122","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41586-024-07791-5","article-title":"Human organoids with an autologous tissue-resident immune compartment","volume":"633","author":"Recaldin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218791_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004400","article-title":"PD-L1 blockade restores CAR T cell activity through IFN-\u03b3-regulation of CD163+ M2 macrophages","volume":"10","author":"Yamaguchi","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218791_bib124","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/1541-7786.MCR-23-0904","article-title":"Clinically relevant humanized mouse models of metastatic prostate cancer facilitate therapeutic evaluation","volume":"22","author":"Kostlan","year":"2024","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.canlet.2026.218791_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1617528","article-title":"A comprehensive welfare scoring system for graft versus host disease clinical assessment in humanised mouse models used for pharmaceutical research","volume":"16","author":"Nowak","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218791_bib126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1878-0261.13376","article-title":"Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts","volume":"17","author":"Wu","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2026.218791_bib127","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/cancers15030699","article-title":"Cell-type-specific signalling networks impacted by prostate epithelial-stromal intercellular communication","volume":"15","author":"Clark","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218791_bib128","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s13402-022-00719-z","article-title":"Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming","volume":"45","author":"Wu","year":"2022","journal-title":"Cell. Oncol. Dordr. Neth."},{"key":"10.1016\/j.canlet.2026.218791_bib129","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1021\/jacs.5c06489","article-title":"\u03bcMap-FFPE: a high-resolution protein proximity labeling platform for formalin-fixed paraffin-embedded tissue samples","volume":"147","author":"Bissonnette","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2026.218791_bib130","article-title":"All-at-once spatial proteome profiling of complex tissue context with single-cell-type resolution by proximity proteomics","volume":"16","author":"Mao","year":"2025","journal-title":"Cell Syst."},{"key":"10.1016\/j.canlet.2026.218791_bib131","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/jcm13030734","article-title":"Prostate cancer liver metastasis: an ominous metastatic site in need of distinct management strategies","volume":"13","author":"Shiner","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib132","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41388-025-03511-z","article-title":"PKA-Driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression","volume":"44","author":"Sanchis","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218791_bib133","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/pros.24055","article-title":"A hemi-spleen injection model of liver metastasis for prostate cancer","volume":"80","author":"Simons","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib134","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.PDX16-B21","article-title":"Abstract B21: establishment of a novel spontaneous prostate cancer liver metastasis model","volume":"22","author":"Zoggel","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218791_bib135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pros.24718","article-title":"Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis","volume":"84","author":"Yin","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218791_bib136","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1038\/s41388-023-02776-6","article-title":"Engineering prostate cancer in vitro: what does it take?","volume":"42","author":"Buskin","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218791_bib137","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41568-022-00527-5","article-title":"Intravital imaging to study cancer progression and metastasis","volume":"23","author":"Entenberg","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218791_bib138","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1016\/j.cell.2024.07.036","article-title":"Multiphoton fluorescence microscopy for in vivo imaging","volume":"187","author":"Xu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218791_bib139","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s43586-022-00168-w","article-title":"Multiphoton intravital microscopy of rodents","volume":"2","author":"Scheele","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.canlet.2026.218791_bib140","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1186\/s12885-018-4905-5","article-title":"The bone microenvironment promotes tumor growth and tissue perfusion compared with striated muscle in a preclinical model of prostate cancer in vivo","volume":"18","author":"Mussawy","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218791_bib141","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5726","article-title":"Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone","volume":"10","author":"Dondossola","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib142","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh0363","article-title":"Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status","volume":"7","author":"Murphy","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218791_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8504","article-title":"Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis","volume":"9","author":"Vennin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib144","doi-asserted-by":"crossref","first-page":"eadf9063","DOI":"10.1126\/sciadv.adf9063","article-title":"Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse","volume":"9","author":"Conway","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218791_bib145","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1080\/15384101.2020.1838779","article-title":"Intravital imaging reveals cell cycle-dependent myogenic cell migration during muscle regeneration","volume":"19","author":"Konagaya","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218791_bib146","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1084\/jem.20182375","article-title":"Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity","volume":"216","author":"Cazaux","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218791_bib147","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl1197","article-title":"Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response","volume":"10","author":"Pereira","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218791_bib148","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/j.celrep.2018.05.038","article-title":"Intravital imaging to monitor therapeutic response in moving hypoxic regions resistant to PI3K pathway targeting in pancreatic cancer","volume":"23","author":"Conway","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/srep25086","article-title":"In vivo visualization of stromal macrophages via label-free FLIM-based metabolite imaging","volume":"6","author":"Szulczewski","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib150","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1038\/s41596-023-00894-9","article-title":"Minimally invasive longitudinal intravital imaging of cellular dynamics in intact long bone","volume":"18","author":"Bhattacharyya","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2026.218791_bib151","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/physrev.00013.2019","article-title":"Stiffness sensing by cells","volume":"100","author":"Janmey","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2026.218791_bib152","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1007\/s00464-013-2906-7","article-title":"Transrectal quantitative shear wave elastography in the detection and characterisation of prostate cancer","volume":"27","author":"Ahmad","year":"2013","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.canlet.2026.218791_bib153","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00330-016-4534-9","article-title":"Stiffness of benign and malignant prostate tissue measured by shear-wave elastography: a preliminary study","volume":"27","author":"Rouvi\u00e8re","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.canlet.2026.218791_bib154","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1148\/radiol.2021201852","article-title":"Tomoelastography based on multifrequency MR elastography for prostate cancer detection: comparison with multiparametric MRI","volume":"299","author":"Li","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.canlet.2026.218791_bib155","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jbio.201600090","article-title":"Second harmonic generation (SHG) imaging of cancer heterogeneity in ultrasound guided biopsies of prostate in men suspected with prostate cancer","volume":"10","author":"Ling","year":"2017","journal-title":"J. Biophot."},{"key":"10.1016\/j.canlet.2026.218791_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303523","article-title":"Changes in tissue fluidity predict tumor aggressiveness in vivo","volume":"10","author":"Sauer","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2026.218791_bib157","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7863\/jum.2011.30.3.387","article-title":"A novel approach to assessing changes in prostate stiffness with age using virtual touch tissue quantification","volume":"30","author":"Zheng","year":"2011","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.canlet.2026.218791_bib158","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1039\/D1SM01291F","article-title":"Whole tissue and single cell mechanics are correlated in human brain tumors","volume":"17","author":"Sauer","year":"2021","journal-title":"Soft Matter"},{"key":"10.1016\/j.canlet.2026.218791_bib159","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/labinvest.2017.132","article-title":"Microscale characterization of prostate biopsies tissues using optical coherence elastography and second harmonic generation imaging","volume":"98","author":"Yuting","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.canlet.2026.218791_bib160","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.3390\/cancers13215553","article-title":"Characterisation of collagen Re-Modelling in localised prostate cancer using second-generation harmonic imaging and transrectal ultrasound shear wave elastography","volume":"13","author":"Ageeli","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218791_bib161","doi-asserted-by":"crossref","DOI":"10.47248\/chp2401020011","article-title":"Heterogeneity of tumor biophysical properties and their potential role as prognostic markers","author":"Markl","year":"2024","journal-title":"Cancer Heterog. Plast."},{"key":"10.1016\/j.canlet.2026.218791_bib162","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.abb.2011.12.013","article-title":"Cancer cell detection in tissue sections using AFM","volume":"518","author":"Lekka","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2026.218791_bib163","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbagen.2012.02.006","article-title":"AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential","volume":"1820","author":"Bastatas","year":"2012","journal-title":"Biochim. Biophys. Acta BBA - Gen. Subj."},{"key":"10.1016\/j.canlet.2026.218791_bib164","author":"Garside"},{"key":"10.1016\/j.canlet.2026.218791_bib165","article-title":"Cancer-associated fibroblasts of the prostate promote a compliant and more invasive phenotype in benign prostate epithelial cells, mater","volume":"8","author":"Jaeschke","year":"2020","journal-title":"Today Bio"},{"key":"10.1016\/j.canlet.2026.218791_bib166","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/CBM-2008-44-505","article-title":"Tissue elasticity properties as biomarkers for prostate cancer","volume":"4","author":"Hoyt","year":"2008","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.canlet.2026.218791_bib167","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/016173469802000403","article-title":"Elastic moduli of breast and prostate tissues under compression","volume":"20","author":"Krouskop","year":"1998","journal-title":"Ultrason. Imag."},{"key":"10.1016\/j.canlet.2026.218791_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202514","article-title":"Precision hydrogels for the study of cancer cell mechanobiology","volume":"12","author":"Sievers","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.canlet.2026.218791_bib169","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","article-title":"Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase","volume":"169","author":"Cantor","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218791_bib170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau7314","article-title":"Improving the metabolic fidelity of cancer models with a physiological cell culture medium","volume":"5","author":"Vande Voorde","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218791_bib171","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cmet.2021.02.005","article-title":"CRISPR screens in physiologic medium reveal conditionally essential genes in human cells","volume":"33","author":"Rossiter","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218791_bib172","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/1541-7786.MCR-22-0796","article-title":"Multi-substrate metabolic tracing reveals marked heterogeneity and dependency on fatty acid metabolism in human prostate cancer","volume":"21","author":"Fidelito","year":"2023","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.canlet.2026.218791_bib173","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41556-023-01274-x","article-title":"Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment","volume":"25","author":"Giafaglione","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218791_bib174","doi-asserted-by":"crossref","first-page":"C823","DOI":"10.1152\/ajpcell.00403.2021","article-title":"Rapid nutrient depletion to below the physiological range by cancer cells cultured in plasmax","volume":"323","author":"Gardner","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.canlet.2026.218791_bib175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41598-024-84297-0","article-title":"A microfluidics platform for simultaneous evaluation of sensitivity and side effects of anti-cancer drugs using a three-dimensional culture method","volume":"15","author":"Kobayashi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib176","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218791_bib177","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.canlet.2026.218791_bib178","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq7305","article-title":"Identifying metabolic limitations in the tumor microenvironment","volume":"10","author":"Cognet","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218791_bib179","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218791_bib180","doi-asserted-by":"crossref","first-page":"R669","DOI":"10.1152\/ajpregu.00036.2018","article-title":"Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer","volume":"315","author":"Hunyor","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.canlet.2026.218791_bib181","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s11033-023-08251-5","article-title":"The role of hypoxia on prostate cancer progression and metastasis","volume":"50","author":"Mohamed","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib182","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41391-023-00666-2","article-title":"PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer","volume":"27","author":"Scheinberg","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2026.218791_bib183","article-title":"Circulating lipid profiles associated with resistance to androgen deprivation therapy in localized prostate cancer","volume":"8","author":"Lin","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218791_bib184","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70161","article-title":"Application of human plasma\/serum to cell culture in vitro: a translational research approach to better define disease mechanisms","volume":"18","author":"Cela","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.canlet.2026.218791_bib185","article-title":"Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention, evid.-based complement","volume":"2011","author":"Soliman","year":"2011","journal-title":"Altern. Med. ECAM"},{"key":"10.1016\/j.canlet.2026.218791_bib186","article-title":"Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells","volume":"123","author":"Portman","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2026.218791_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115432","article-title":"The tumor microenvironment is an ecosystem sustained by metabolic interactions","volume":"44","author":"Kay","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218791_bib188","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.euo.2018.04.019","article-title":"Patient-derived models reveal impact of the tumor microenvironment on therapeutic response","volume":"1","author":"Shafi","year":"2018","journal-title":"Eur. Urol. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:35:35Z","timestamp":1789108535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":188,"alternative-id":["S0304383526005550"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218791","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218791"}}